Eosinophil secretion of granule-derived cytokines

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Spencer, Lisa A ^a   Bonjour, Kennedy ^b   Melo, Rossana C N ^b   Weller, Peter F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Cytokine; Cytolysis; Degranulation; Eosinophil; Granule; Piecemeal degranulation; Secretion

Indexed keywords

CYTOKINE; DNA; EOTAXIN; GAMMA INTERFERON; LEUKOTRIENE;

CELL CYCLE REGULATION; CELL GRANULE; CELL MIGRATION; CELLULAR SECRETION; DEGRANULATION; ENZYME PHOSPHORYLATION; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; INFLAMMATORY BOWEL DISEASE; LEUKOCYTE; REVIEW; TISSUE REGENERATION; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING;

EID: 84919329413     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00496     Document Type: Review

References (67)

1. Spry CJF. Eosinophils: A Comprehensive Review and Guide to the Scientific and Medical Literature. Oxford: Oxford Medical Publications (1988).
2. Acharya KR, Ackerman SJ. Eosinophil granule proteins: form and function. J Biol Chem (2014) 289(25):17406-15. doi:10.1074/jbc. R113.546218
3. Wong DT, Weller PF, Galli SJ, Elovic A, Rand TH, Gallagher GT, et al. Human eosinophils express transforming growth factor alpha. J Exp Med (1990) 172(3):673-81. doi:10.1084/jem.172.3.673
4. Moqbel R, Coughlin JJ. Differential secretion of cytokines. Sci STKE (2006) 2006(338):e26. doi:10.1126/stke.3382006pe26
5. Beil WJ, Weller PF, Tzizik DM, Galli SJ, Dvorak AM. Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochem Cytochem (1993) 41(11):1611-5. doi:10.1177/41.11.8409368
6. Spencer LA, Szela CT, Perez SA, Kirchhoffer CL, Neves JS, Radke AL, et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol (2009) 85(1):117-23. doi:10.1189/jlb.0108058
7. Bandeira-Melo C, Sugiyama K, Woods LJ, Weller PF. Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol (2001) 166(8):4813-7. doi:10.4049/jimmunol.166.8.4813
8. Miyamasu M, Hirai K, Takahashi Y, Iida M, Yamaguchi M, Koshino T, et al. Chemotactic agonists induce cytokine generation in eosinophils. J Immunol (1995) 154(3):1339-49.
9. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol (1989) 142(7):2393-400.
10. Wong CK, Cheung PF, Ip WK, Lam CW. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol (2007) 37(1):85-96. doi:10.1165/rcmb.2006-0457OC
11. Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development (2000) 127(11):2269-82.
12. Robertson SA, Mau VJ, Hudson SN, Tremellen KP. Cytokine-leukocyte networks and the establishment of pregnancy. Am J Reprod Immunol (1997) 37(6):438-42. doi:10.1111/j.1600-0897.1997.tb00257.x
13. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science (2011) 332(6026):243-7. doi:10.1126/science.1201475
14. Wang HB, Weller PF. Pivotal advance: eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production. J Leukoc Biol (2008) 83(4):817-21. doi:10.1189/jlb.0607392
15. Chu VT, Frohlich A, Steinhauser G, Scheel T, Roch T, Fillatreau S, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol (2011) 12(2):151-9. doi:10.1038/ni.1981
16. Chu VT, Beller A, Rausch S, Strandmark J, Zanker M, Arbach O, et al. Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. Immunity (2014) 40(4):582-93. doi:10.1016/j.immuni.2014.02.014
17. Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, Colbert DC, et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med (2008) 205(3):699-710. doi:10.1084/jem.20071840
18. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 142(12):4428-34.
19. Nakajima M, Hirakata M, Nittoh T, Ishihara K, Ohuchi K. Expression and purification of recombinant rat eosinophil-associated ribonucleases, homologues of human eosinophil cationic protein and eosinophil-derived neurotoxin, and their characterization. Int Arch Allergy Immunol (2001) 125(3):241-9. doi:10.1159/000053822
20. Persson T, Andersson P, Bodelsson M, Laurell M, Malm J, Egesten A. Bactericidal activity of human eosinophilic granulocytes against Escherichia coli. Infect Immun (2001) 69(6):3591-6. doi:10.1128/IAI.69.6.3591-3596.2001
21. Linch SN, Kelly AM, Danielson ET, Pero R, Lee JJ, Gold JA. Mouse eosinophils possess potent antibacterial properties in vivo. Infect Immun (2009) 77(11):4976-82. doi:10.1128/IAI.00306-09
22. YousefiS, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med (2008) 14(9):949-53. doi:10.1038/nm.1855
23. Yoon J, Ponikau JU, Lawrence CB, Kita H. Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b. J Immunol (2008) 181(4):2907-15. doi:10.4049/jimmunol.181.4.2907
24. Matsuwaki Y, Wada K, White TA, Benson LM, Charlesworth MC, Checkel JL, et al. Recognition of fungal protease activities induces cellular activation and eosinophil-derived neurotoxin release in human eosinophils. J Immunol (2009) 183(10):6708-16. doi:10.4049/jimmunol.0901220
25. Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol (2005) 175(8):5439-47. doi:10.4049/jimmunol.175.8.5439
26. Todd R, DonoffBR, Chiang T, Chou MY, Elovic A, Gallagher GT, et al. The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am J Pathol (1991) 138(6):1307-13.
27. Aceves SS, Broide DH. Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma. Curr Mol Med (2008) 8(5):350-8. doi:10.2174/156652408785161023
28. Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy (2010) 65(8):946-58. doi:10.1111/j.1398-9995.2010.02372.x
29. Puxeddu I, Alian A, Piliponsky AM, Ribatti D, Panet A, Levi-Schaffer F. Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol (2005) 37(3):628-36. doi:10.1016/j.biocel.2004.09.001
30. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol (2001) 107(2):295-301. doi:10.1067/mai.2001.115626
31. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol (2001) 107(6):1034-8. doi:10.1067/mai.2001.115626
32. Jacobsen EA, Zellner KR, Colbert D, Lee NA, Lee JJ. Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J Immunol (2011) 187(11):6059-68. doi:10.4049/jimmunol.1102299
33. Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med (2006) 203(6):1435-46. doi:10.1084/jem.20052448
34. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity (2004) 20(3):267-77. doi:10.1016/S1074-7613(04)00026-3
35. MacKenzie JR, Mattes J, Dent LA, Foster PS. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol (2001) 167(6):3146-55. doi:10.4049/jimmunol.167.6.3146
36. Shi HZ, Xiao CQ, Li CQ, Mo XY, Yang QL, Leng J, et al. Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses. Allergy (2004) 59(4):428-35. doi:10.1046/j.1398-9995.2003.00405.x
37. Yang D, Chen Q, Su SB, Zhang P, Kurosaka K, Caspi RR, et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med (2008) 205(1):79-90. doi:10.1084/jem.20062027
38. Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, Pero R, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol (2006) 79(6):1131-9. doi:10.1189/jlb.0106027
39. Samoszuk M. Eosinophils and human cancer. Histol Histopathol (1997) 12(3):807-12.
40. Erjefalt JS, GreiffL, Andersson M, Adelroth E, Jeffery PK, Persson CG. Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax (2001) 56(5):341-4. doi:10.1136/thorax.56.5.341
41. Saffari H, Hoffman LH, Peterson KA, Fang JC, Leiferman KM, Pease LF III, et al. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol (2014) 133(6):1728-34e1. doi:10.1016/j.jaci.2013.11.024
42. Dvorak HF, Dvorak AM. Basophilic leucocytes: structure, function and role in disease. Clin Haematol (1975) 4(3):651-83.
43. Melo RCN, Perez SA, Spencer LA, Dvorak AM, Weller PF. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic (2005) 6(10):866-79. doi:10.1111/j.1600-0854.2005.00322.x
44. Melo RCN, Spencer LA, Dvorak AM, Weller PF. Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. J Leukoc Biol (2008) 83(2):229-36. doi:10.1189/jlb.0707503
45. Melo RCN, Spencer LA, Perez SA, Ghiran I, Dvorak AM, Weller PF. Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic (2005) 6(11):1047-57. doi:10.1111/j.1600-0854.2005.00344.x
46. Melo RCN, Dvorak AM, Weller PF. Electron tomography and immunonanogold electron microscopy for investigating intracellular trafficking and secretion in human eosinophils. J Cell Mol Med (2008) 12(4):1416-9. doi:10.1111/j.1582-4934.2008.00346.x
47. Spencer LA, Melo RCN, Perez SA, Bafford SP, Dvorak AM, Weller PF. Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc Natl Acad Sci U S A (2006) 103(9):3333-8. doi:10.1073/pnas.0508946103
48. Melo RCN, Spencer LA, Perez SA, Neves JS, Bafford SP, Morgan ES, et al. Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. Lab Invest (2009) 89(7):769-81. doi:10.1038/labinvest.2009.40
49. Egesten A, Calafat J, Knol EF, Janssen H, Walz TM. Subcellular localization of transforming growth factor-alpha in human eosinophil granulocytes. Blood (1996) 87(9):3910-8.
50. Koenderman L. Priming: a critical step in the control of eosinophil activation. In: Lee JHF, Rosenberg HF, editors. Eosinophils in Health and Disease. Boston, MA: Elsevier (2013). p. 170-8.
51. Pazdrak K, Young TW, Straub C, Stafford S, Kurosky A. Priming of eosinophils by GM-CSF is mediated by protein kinase CbetaII-phosphorylated l-plastin. J Immunol (2011) 186(11):6485-96. doi:10.4049/jimmunol.1001868
52. Bandeira-Melo C, Hall JC, Penrose JF, Weller PF. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J Allergy Clin Immunol (2002) 109(6):975-9. doi:10.1067/mai.2002.124269
53. Bandeira-Melo C, Woods LJ, Phoofolo M, Weller PF. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med (2002) 196(6):841-50. doi:10.1084/jem.20020516
54. Neves JS, Radke AL, Weller PF. Cysteinyl leukotrienes acting via granule membrane expressed receptors elicit secretion from within cell-free human eosinophil granules. J Allergy Clin Immunol (2010) 125(2):477-82. doi:10.1016/j.jaci.2009.11.029
55. Lacy P, Moqbel R. Signaling and degranulation. In: Lee JJ, Rosenberg HF, editors. Eosinophils in Health and Disease. Boston, MA: Elsevier (2013). p. 206-19.
56. Persson CG, Erjefalt JS. "Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs). Thorax (1997) 52(6):569-74. doi:10.1136/thx.52.6.569
57. Erjefalt JS, Sundler F, Persson CG. Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med (1996) 153(5):1666-74. doi:10.1164/ajrccm.153.5.8630618
58. Ueki S, Melo RCN, Ghiran I, Spencer LA, Dvorak AM, Weller PF. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood (2013) 121(11):2074-83. doi:10.1182/blood-2012-05-432088
59. Cheng JF, Ott NL, Peterson EA, George TJ, Hukee MJ, Gleich GJ, et al. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol (1997) 99(5):683-92. doi:10.1016/S0091-6749(97)70031-9
60. Weiler CR, Kita H, Hukee M, Gleich GJ. Eosinophil viability during immunoglobulin-induced degranulation. J Leukoc Biol (1996) 60(4):493-501.
61. Fukuda T, Ackerman SJ, Reed CE, Peters MS, Dunnette SL, Gleich GJ. Calcium ionophore A23187 calcium-dependent cytolytic degranulation in human eosinophils. J Immunol (1985) 135(2):1349-56.
62. Kano G, Almanan M, Bochner BS, Zimmermann N. Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation. J Allergy Clin Immunol (2013) 132(2):437-45. doi:10.1016/j.jaci.2013.03.024
63. Prince LR, Graham KJ, Connolly J, Anwar S, Ridley R, Sabroe I, et al. Staphylococcus aureus induces eosinophil cell death mediated by alpha-hemolysin. PLoS One (2012) 7(2):e31506. doi:10.1371/journal.pone.0031506
64. Persson C, Uller L. Theirs but to die and do: primary lysis of eosinophils and free eosinophil granules in asthma. Am J Respir Crit Care Med (2014) 189(6):628-33. doi:10.1164/rccm.201311-2069OE
65. Morshed M, YousefiS, Stockle C, Simon HU, Simon D. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy (2012) 67(9):1127-37. doi:10.1111/j.1398-9995.2012.02868.x
66. Neves JS, Weller PF. Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology. Curr Opin Immunol (2009) 21(6):694-9. doi:10.1016/j.coi.2009.07.011
67. Neves JS, Perez SA, Spencer LA, Melo RCN, Reynolds L, Ghiran I, et al. Eosinophil granules function extracellularly as receptor-mediated secretory organelles. Proc Natl Acad Sci U S A (2008) 105(47):18478-83. doi:10.1073/pnas.0804547105